2023
DOI: 10.1016/j.bmc.2023.117503
|View full text |Cite
|
Sign up to set email alerts
|

Design, synthesis and SAR of novel 7-azaindole derivatives as potential Erk5 kinase inhibitor with anticancer activity

Qin Zhang,
Xintao Gao,
Xiyu Duan
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 33 publications
0
1
0
Order By: Relevance
“…[198] Given that most research underscores ERK5's role in fostering cancer progression, current drug development targeting ERK5 predominantly focuses on inhibitors. Presently, XMD8-92 [204,205], BIX02188, and BIX02189 [206] are extensively utilized, alongside various natural or synthetic compounds, largely informed by findings from other cancer studies [148,198,[207][208][209][210][211][212][213][214][215][216]. Although significant advancements have been made in targeted osteosarcoma therapy in recent years [217], research on targeting ERK5 in osteosarcoma treatment remains scarce.…”
Section: Drugsmentioning
confidence: 99%
“…[198] Given that most research underscores ERK5's role in fostering cancer progression, current drug development targeting ERK5 predominantly focuses on inhibitors. Presently, XMD8-92 [204,205], BIX02188, and BIX02189 [206] are extensively utilized, alongside various natural or synthetic compounds, largely informed by findings from other cancer studies [148,198,[207][208][209][210][211][212][213][214][215][216]. Although significant advancements have been made in targeted osteosarcoma therapy in recent years [217], research on targeting ERK5 in osteosarcoma treatment remains scarce.…”
Section: Drugsmentioning
confidence: 99%